Profile
PLRZ VRTX REGN ALNY SGEN ARGX
Company Name Polyrizon Ltd. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $3.77M $117.98B $60.26B $43.28B $43.15B $34.40B
Employees 0.00K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Tomer Izraeli Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
PLRZ VRTX REGN ALNY SGEN ARGX
Quant Rating Score 1 2 4 1 3 2
Quant Rating Strong Sell Sell Buy Strong Sell Neutral Sell
Trading
PLRZ VRTX REGN ALNY SGEN ARGX
Last Close $0.707 $468.85 $567.74 $314.94 $228.74 $560.24
High 52 $3.04 $516.74 $1201.76 $331.91 $228.74 $671.75
Low 52 - $396.64 $482.92 $224.58 $228.74 $461.01
Price vs. 52 Week High -76.74 % -9.27 % -52.76 % -5.11 % 0 % -16.6 %
Price vs. 52 Week Low 0 % 18.21 % 17.56 % 40.24 % 0 % 21.52 %
Total Return
PLRZ VRTX REGN ALNY SGEN ARGX
1 Month Return -15.33 % 2.94 % 7.27 % 2.26 % 0 % -3.05 %
3 Month Return 84.74 % -5.44 % -0.46 % 31.22 % 0 % -7.62 %
6 Month Return -51.24 % 13.89 % -17.82 % 30.95 % 0 % -15.83 %
9 Month Return 0 % -3.29 % -44.02 % 11.16 % 0 % 3.07 %
YTD Return -67.42 % 16.43 % -20.3 % 33.84 % 0 % -8.9 %
1 Year Return 0 % -4.07 % -48.39 % 20.89 % 0 % 20.11 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
PLRZ VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.31 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -3.53 % 3.85 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
PLRZ VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 86.01 % 79.1 % 46.33 %
Return on Assets TTM -27.85 % -4.32 % 11.98 % -6.4 % -16.61 % 13.45 %
Return on Equity TTM -56.1 % -6.25 % 14.77 % -509.33 % -20.8 % 16.83 %
Return on Capital Employed TTM -24.63 % -3.89 % 11.35 % -3.68 % -21.46 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 75.89 % 101.33 % 25990.14 %
EBT Per Ebit TTM 118.66 % 40.44 % 129.3 % 308.03 % 98.26 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -4.91 % -31.24 % -1.24 %
Cash Flow To Debt Ratio TTM - -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 5.62 3.91 2.46
Payables Turnover TTM - 3.49 3.01 3.37 1.97 2.39
Inventory Turnover TTM - 1.14 0.66 5.01 0.96 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 337.41 % 665.41 % 4929.48 %
Asset Turnover TTM - 48.51 % 37.52 % 55.72 % 53.41 % 35.83 %
Operating Cash Flow Per Share TTM -0.27 -3.82 37.05 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM -0.27 -4.9 28.3 -0.58 -2.88 -1.09
Cash Per Share TTM 60.89 % 2413.86 % 7825.12 % 2024.29 % 939.52 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -1.92 % -23.12 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 128.33 % 76.4 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM - -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Price To Free Cash Flows Ratio TTM -3.28 -93.78 19.95 -574.08 -81.26 -443.33
Price To Operating Cash Flows Ratio TTM -2.59 -120.39 15.32 -954.11 -93.1 -526.76
Price Cash Flow Ratio TTM -2.59 -120.39 15.32 -954.11 -93.1 -526.76
Income Statement (TTM)
PLRZ VRTX REGN ALNY SGEN ARGX
Revenue $0B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $0B $9.49B $12.23B $1.92B $1.55B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 85.62% 79.1% 89.62%
EBITDA $-0B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted 0.5 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
PLRZ VRTX REGN ALNY SGEN ARGX
Long Term Debt $0B $1.66B $1.98B $0B $0.04B $0.03B
Total Liabilities $0B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0.01B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.01B $22.53B $37.76B $4.3B $3.67B $6.2B
Cash Flow Statement (TTM)
PLRZ VRTX REGN ALNY SGEN ARGX
Net Income $-0B $-0.54B $4.41B $-0.28B $-0.61B $-0.02B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 36.25
AARD Aardvark Therapeutics, Inc. Common Stock 12.04
ABCL AbCellera Biologics Inc. 4.2324
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.8794
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.4801
ABPWW 0.0375
ABSI Absci Corporation 2.655
ABUS Arbutus Biopharma Corporation 3.235
ABVC ABVC BioPharma, Inc. 3.5099
ABVX Abivax SA American Depositary Shares 8.79
ACAD ACADIA Pharmaceuticals Inc. 21.895
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7689
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.745
ACIU AC Immune SA 2.08
Unlock